Kev

Day trade futures, swing trade equities. wannabe troll. “I have no idea what I’m doing but I know I’m doing it really really well” - Andy Dwyer

[greg @greg16676935420]

Boobs are back

[Adam Mancini @AdamMancini4]

Big Picture View: April 30, #ES_F broke out a 1 week bull flag at 7186. I was looking for run to 7546. Now, ES is building a new big bull flag from 7355 to 7515.

Plan Next Week: Fill it out. 7415 (watch traps), 7355=supports. Next leg up targets 7555, 7578, 7630, 7710. Sell<7355

[Kev @kevtrades]

@Jake__Wujastyk $HIMS 👀

[Kev @kevtrades]

Don’t worry fidelity, TPT has me covered

[Kev @kevtrades]

Big end of day push for $HIMS, last hour made the weekly go red to green. Next stop $40

[Kev @kevtrades]

Slow April, just one TPT payout at the beginning of the month. Passed some Tradeify evals. Missed most of the move up, but also didn’t blow anything trying to chase. Going into May with:
5 TPTs
5 Tradeify
5 Topstep
5 Lucid Evals (halfway passed)

[mon @moninvestor]

Which day of the week generates the most returns?

Tuesday: 209%
Wenesday: 156%
Monday: 113%
Friday: 59%
Thursday: 10%

[Za @ZaStocks]

If the last few weeks have emphasized anything it’s that you can make your entire year in a hot market.

Hot markets always come back. The goal is to mostly avoid the bad environments and press when the good ones come.

October-March was choppy. If you had just taken a step back and resumed in April as momentum returned and the market started absorbing bad news, you could’ve made up a lot of ground quickly.

[Kev @kevtrades]

$HIMS to 100

[Secretary Kennedy @SecKennedy]

Today, we took long-overdue action to restore science, accountability, and the rule of law.

In September 2023, the Biden FDA pushed a number of peptides into Category 2 — “Bulk Drug Substances that Raise Significant Safety Risks” — driving a dangerous black market that puts Americans at risk.

Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2 and will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence.

• BPC-157
• Thymosin beta-4 fragment (LKKTETQ)
• Epitalon
• GHK-Cu (injectable)
• MOTS-c
• DSIP (Emideltide)
• Dihexa Acetate
• Ibutamoren Mesylate
• Melanotan II
• KPV
• Semax (heptapeptide)
• Cathelicidin LL-37

This action begins to restore regulated access and will immediately begin shifting demand away from the black market.

We will follow the science, enforce the law, and deliver the clarity patients, providers, and pharmacies deserve.

[Negligible Capital @negligible_cap]

The name of the company… NewBird AI. It is a cutting-edge, AI-native cloud infrastructure firm out of- well, they used to be out of San Francisco making sneakers, but forget that, John- they are now awaiting imminent deployment of next-generation GPU compute clusters that have both massive enterprise and consumer applications. Now, right now, John, the stock trades on the Nasdaq at about the price of a cup of coffee. And by the way, John, our analysts indicate it could go a heck of a lot higher than that. And John- one more thing- they're up 160% just today

[Kev @kevtrades]

Which shitco is next? BeyondAI? AMC AI?

[The Kobeissi Letter @KobeissiLetter]

BREAKING: Allbirds stock, $BIRD, surges over +200% after announcing they are pivoting from shoes to AI.

[High Yield Harry @HighyieldHarry]

The Plan? Pivot Allbirds into an AI company.

[Kev @kevtrades]

Also built in an inactivity tracker that pops up as soon as I open the dashboard, only if there are accounts within 2 days of being cancelled due to inactivity

[Kev @kevtrades]

Built myself a little dashboard for tracking prop expenses and payouts. Had an ok Q1, stayed positive due to TPT payouts. ROI was nice but net earnings could’ve been higher. In this market green is a win though. All that matters is money in > money out. On to Q2

[Kev @kevtrades]

$HIMS to 100

[Hims House @himshouse]

🚨 BREAKING: FDA IS EXPECTED TO LIFT RESTRICTION ON PEPTIDES - NEW YORK TIMES

$HIMS $LLY $NVO

[Kev @kevtrades]

Take max payout ➡️ fund personal account. Rinse and repeat. Was hoping to run up these live accounts but nothings guaranteed in the prop world. Onto the next

[Kev @kevtrades]

The CEO literally admits the company is a shitshow and doesn’t know if he wants to put in the effort to fix it 🤣. Do better @fundingticks @Khldfx

[Kev @kevtrades]

@jmutrades @fundingticks Moral of the story, never trust firms that have FT as the first two initials 😂

[Kev @kevtrades]

The CEO literally admits the company is a shitshow and doesn’t know if he wants to put in the effort to fix it 🤣. Do better @fundingticks @Khldfx

[Kev @kevtrades]

@AdamSliverTrade